(Alliance News) - Baillie Gifford European Growth Trust PLC on Tuesday said its net asset value rose during its most recent financial year, despite "volatility" in its long-term growth strategies. The ...

In New York, markets were mixed. The Dow Jones Industrial Average was up 0.1% at the time of the closing bell in London. The S&P 500 was 0.3% lower, and the Nasdaq Composite lost 0.9%. Investors were ...

(Alliance News) - JPMorgan European Growth & Income PLC on Wednesday said its half-year returns underperformed its benchmark due to "a tricky backdrop of lowering growth expectations and geopolitical ...

(Alliance News) - Galantas Gold Corp on Wednesday reported a narrowed loss despite generating no revenue in the quarter. Galantas is a gold mining company focused in Northern Ireland and Scotland.

(Sharecast News) - London markets posted modest gains on Wednesday, following a key US inflation reading that showed relative stability in price rises in October. The FTSE 100 index climbed 0.2% to ...

Mercia raised GBP57 million for its managed funds during the period, including GBP29.2 million for its Northern Venture Capital Trusts and GBP10 million for the Northern Powerhouse Investment Fund.

(Alliance News) - Microsaic Systems PLC on Tuesday announced progress on a project in Qatar. The Surrey-based developer of real-time mass spectrometers confirmed that all 27 continuous toxic ...

Virgin Money Uk Share Chat. Chat About VMUK Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.

Inqo swung to a pretax profit of ZAR1.3 million, about GBP56,899, in the six months to the end of August from a loss of ZAR4.3 million a year before, as revenue increased by 11% to ZAR8.2 million from ...

Games Workshop Group PLC - Nottingham, England-based miniature wargames maker and retailer - Promotes Non-Executive Director Randal Casson to senior independent director, effective immediately. Casson ...

(Alliance News) - Tectonic Gold PLC on Wednesday reported a narrowed loss for its financial year ended June 30, reflecting improved cost controls and a shift in strategy following asset transactions.

The European Patent Office will issue a formal grant for TheraCryf's drug, the 'Ox-1' receptor anatagonist, on December 18. The drug was developed by British biotech firm Chronos Therapeutics Ltd, ...